SCHEMBL9309841

SCHEMBL9309841

CCc1nc(C)c(C=O)n1Cc1ccc2oc(-c3ccccc3C(=O)OC)c(Br)c2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9309342 0.94 AGTR1 (0.42)
SCHEMBL9309479 0.92 AGTR1 (0.48)
SCHEMBL9309270 0.91
SCHEMBL9309850 0.90
SCHEMBL9309392 0.88 AGTR1 (0.51)
SCHEMBL9694822 0.85 AGTR1 (0.57)
SCHEMBL9309349 0.84
SCHEMBL9310994 0.83 AGTR1 (0.61)
SCHEMBL9678069 0.83
SCHEMBL9309485 0.82 AGTR1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5374646-A Treatment or prophylasix of hypertension and diseases associated with cognitive disorders GLAXO GROUP LIMITED (GB) 1994-12-20 US disclosed
WO-1992016552-A1 1-IMIDAZOLGEMETHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF ANGIOTENSIN II ACTIVITY GLAXO GROUP LIMITED (GB) 1992-10-01 WO disclosed
EP-0505954-A1 N-Imidazolylmethyl benzofuran derivatives as inhibitors of angiotensin II activity GLAXO GROUP LIMITED (GB) 1992-09-30 EP disclosed